Study Tests Treatment of Cancer Patients with Ecstasy A new study being conducted by Harvard researchers will examine how the psychedelic drug Ecstasy might help advanced-stage cancer patients suffering from anxiety. Melissa Block talks with principal investigator Dr. John Halpern of Harvard's McLean Hospital.

Study Tests Treatment of Cancer Patients with Ecstasy

Listen

Download
Embed <iframe src="https://www.npr.org/player/embed/4510521/4510522" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Study Tests Treatment of Cancer Patients with Ecstasy

Health Care

Study Tests Treatment of Cancer Patients with Ecstasy

Listen

Download
Embed <iframe src="https://www.npr.org/player/embed/4510521/4510522" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

February 23, 200512:00 AM ET

Heard on All Things Considered

Melissa Block

Facebook Twitter Instagram

A new study being conducted by Harvard researchers will examine how the psychedelic drug Ecstasy might help advanced-stage cancer patients suffering from anxiety. Melissa Block talks with principal investigator Dr. John Halpern of Harvard's McLean Hospital.